Fights All Resistant Infections :

• Pharmacokinetic of this drug is not affected by presence of hepatic dysfunction
• Exhibits 92% efficacy as compared to 88% with Amoxy -Clavulanate combination
• Specifically used in febrile neutropenic patients with haematological malignancies & burns

Indications :

• Febrile neutropenic patients
• Bacterial arthritis
• Pseudomonas meningitis
• Immuocompromised Infections
• Skin, Soft tissue & bone Infections
• Septicaemia